Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 3
2016 3
2017 2
2018 2
2019 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.
Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA; LEAP Study Group. Verschuur CVM, et al. Among authors: boel ja. N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983. N Engl J Med. 2019. PMID: 30673543 Clinical Trial.
Author response.
Odekerken VJ, Boel JA, Schmand BA, de Bie RM. Odekerken VJ, et al. Among authors: boel ja. Neurology. 2015 Oct 20;85(16):1433-4. Neurology. 2015. PMID: 26771041 No abstract available.
Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.
Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D; IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. Hoogland J, et al. Among authors: boel ja. Mov Disord. 2018 Nov;33(11):1750-1759. doi: 10.1002/mds.110. Epub 2018 Sep 14. Mov Disord. 2018. PMID: 30216541 Free PMC article. Review.
Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. Hoogland J, et al. Among authors: boel ja. Mov Disord. 2019 Mar;34(3):430-435. doi: 10.1002/mds.27617. Epub 2019 Jan 17. Mov Disord. 2019. PMID: 30653248
Mild cognitive impairment as a risk factor for Parkinson's disease dementia.
Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. Hoogland J, et al. Among authors: boel ja. Mov Disord. 2017 Jul;32(7):1056-1065. doi: 10.1002/mds.27002. Epub 2017 Jun 12. Mov Disord. 2017. PMID: 28605056
Neuropsychological outcome after deep brain stimulation for Parkinson disease.
Odekerken VJ, Boel JA, Geurtsen GJ, Schmand BA, Dekker IP, de Haan RJ, Schuurman PR, de Bie RM; NSTAPS Study Group. Odekerken VJ, et al. Among authors: boel ja. Neurology. 2015 Mar 31;84(13):1355-61. doi: 10.1212/WNL.0000000000001419. Epub 2015 Feb 27. Neurology. 2015. PMID: 25724233 Clinical Trial.
GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.
Odekerken VJ, Boel JA, Schmand BA, de Haan RJ, Figee M, van den Munckhof P, Schuurman PR, de Bie RM; NSTAPS study group. Odekerken VJ, et al. Among authors: boel ja. Neurology. 2016 Feb 23;86(8):755-61. doi: 10.1212/WNL.0000000000002401. Epub 2016 Jan 27. Neurology. 2016. PMID: 26819458 Clinical Trial.
Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia.
Boel JA, de Bie RMA, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group Mild Cognitive Impairment in Parkinson's Disease. Boel JA, et al. Mov Disord Clin Pract. 2022 Apr 29;9(4):479-483. doi: 10.1002/mdc3.13451. eCollection 2022 May. Mov Disord Clin Pract. 2022. PMID: 35582313 Free PMC article.
13 results